Concourse Financial Group Securities, Inc. Artivion, Inc. Transaction History
Concourse Financial Group Securities, Inc.
- $0
- Q2 2025
Number of Shares
0
Previous 0
NaN%
Holding current value
$0
Previous $0
NaN%
% of portfolio
100.0%
Previous 100.0%
Shares
29 transactions
Others Institutions Holding AORT
# of Institutions
205Shares Held
40.5MCall Options Held
19.2KPut Options Held
0-
Black Rock Inc. New York, NY6.64MShares$298 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.03MShares$136 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C32.96MShares$133 Million0.12% of portfolio
-
Perceptive Advisors LLC New York, NY2.79MShares$125 Million3.82% of portfolio
-
Morgan Stanley New York, NY2.32MShares$104 Million0.0% of portfolio
About ARTIVION, INC.
- Ticker AORT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 40,316,100
- Market Cap $1.81B
- Description
- Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...